Defective platelet aggregation in response to platelet-activating factor in uremia associated with low platelet thromboxane A2 generation
D Macconi, G Viganô, G Bisogno, M Galbusera… - American journal of …, 1992 - Elsevier
The bleeding tendency associated with uremia is likely due to a qualitative platelet
dysfunction. So far the data available on platelet aggregation are conflicting. Since platelet …
dysfunction. So far the data available on platelet aggregation are conflicting. Since platelet …
Increased production of prostacyclin after injury to the microvasculature in uraemic patients
W Slazus - 1992 - scholar.sun.ac.za
A recently described method to evaluate the primary haemostatic mechanism under in vivo
conditions was utilised to investigate thromboxane A2 (TXA2) and prostacyclin (PC12) …
conditions was utilised to investigate thromboxane A2 (TXA2) and prostacyclin (PC12) …
Elevated Levels of Plasma and Urine Beta-Thromboglobulin or Thromboxane-B2as Markers of Real Platelet Hyperactivation in Diabetic Nephropathy
L Romicsh - 1992 - karger.com
Serum creatinine, immunoreactive serum and urine (^-microglobulin, plasma and urine
thromboglobulin, plasma thromboxane-B? levels and daily protein excretion were …
thromboglobulin, plasma thromboxane-B? levels and daily protein excretion were …
[引用][C] Cardiovascular disease in patients with end‐stage renal failure
SC Greaves, DN Sharpe - Australian and New Zealand journal …, 1992 - Wiley Online Library
Patients with end-stage renal disease have a high cardiovascular mortality, particularly from
coronary artery disease. This review will focus on the aetiology and manifestations of …
coronary artery disease. This review will focus on the aetiology and manifestations of …